Healthcare Industry News: pulse oximetry
News Release - October 13, 2006
Nihon Kohden America, Inc. and Masimo Announce Patient Monitoring Agreement
IRVINE, Calif.--(HSMN NewsFeed)--Nihon Kohden America, Inc., recognized as the fastest growing monitoring company in the United States, announced the signing of an agreement with Masimo Corporation. This new product offering will allow Nihon Kohden to integrate Masimo SET (Signal Extraction Technology) into their advanced line of bedside and patient monitoring products.Masimo SET pulse oximetry is a highly advanced method of acquiring, processing and reporting arterial oxygen saturation and pulse rate. Combining proprietary signal processing algorithms with innovative sensor design, Masimo SET pulse oximetry enables adaptive filters to work in real time to accurately report changes in human physiology. Masimo SET SpO(2) technology has been clinically proven to read through motion and low perfusion at a high level of accuracy, with studies showing improved patient outcomes.
Nihon Kohden is known for their advanced line of Patient Monitoring products and innovation 'firsts', including Smart Modular Cable(TM) and sensor miniaturization technology, wireless network systems and remote access monitoring. In addition, Nihon Kohden offers a renowned 5-year parts and labor warranty as standard on all of their bedside monitoring products.
Mike Dashefsky, Vice President of Nihon Kohden Patient Monitoring Business group, states, "Nihon Kohden America adheres to the 'Smarter is Better' approach, which focuses on providing smarter technologies and better solutions to our customers. Our alliance with Masimo, the innovator of motion and low perfusion tolerant pulse oximetry, corresponds with this philosophy, and we are proud to integrate Masimo SET into our advanced line of patient monitoring products."
Rick Fishel, President of Masimo Americas stated, "We are proud to establish a partnership with Nihon Kohden America which has been recognized as the fastest growing patient monitoring company in the U.S., and we look forward to a long, mutually beneficial partnership for both companies."
About Nihon Kohden America
Nihon Kohden America was founded in 1979 as a wholly owned subsidiary of Nihon Kohden Corporation, Japan (founded in 1951). Nihon Kohden America is a market leader in Patient Monitoring, Sleep Assessment, Neurology and Cardiology instrumentation. Our products are distributed to hospitals, physicians' practices, mobile services, and outpatient and surgery centers throughout North America. More information about Nihon Kohden America can be found at www.nkusa.com.
About Masimo Corporation
Masimo, founded in 1989, is the inventor and leader of Signal Extraction Technology for the non-invasive monitoring of vital signs. Masimo Signal Extraction Technology, or Masimo SET, represents the standard of care for pulse oximeters. With its worldwide introduction in 1998, Masimo SET overcame data dropouts, false alarms and inaccurate measurements due to patient motion, low perfusion and other challenging conditions. Over 100 clinical studies support the conclusion that Masimo SET is the most effective pulse oximeter in the world. Additional information about Masimo and its products can be found at www.masimo.com.
Source: Nihon Kohden
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
